FDA inspection
Megafine Pharma (P) Limited: FDA inspection ending Sep 23, 2016
FDA inspection 988000 · Official Action Indicated (OAI) · Vapi
Key facts
| Inspection ID | 988000 |
|---|---|
| Firm | Megafine Pharma (P) Limited |
| FEI number | 3006688078 |
| Address | 911 & 912, Phase Iii Gidc |
| City | Vapi |
| Country | India |
| Fiscal year | 2016 |
| Inspection end date | Sep 23, 2016 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 510862 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data